Home > News > Starpharma: A Buying Opportunity?
June 22nd, 2006
Starpharma: A Buying Opportunity?
Abstract:
Jack Uldrich: Yesterday, shares of Starpharma’s ADR (Advance Deposit Receipts) plummetted 25 percent on no discernible news. I was surprised and disappointed by the drop — especially because I had just bought more shares the other day when the stock (Nasdaq: SPHRY) was trading at $3.50 and I didn’t think it could go any lower.
Source:
NanoNovus
Bookmark:
| Related Links |
| Related News Press |
Investments/IPO's/Splits
Harris & Harris Group Announces the Filing of Preliminary Proxy Materials Detailing Its Proposed Conversion From a BDC to a Registered Closed-End Fund January 24th, 2017
Harris & Harris Group Issues Reminder for Shareholder Update Call on January 10, 2017 January 10th, 2017
Announcements
Rice U. chemists create 3-D printed graphene foam June 22nd, 2017
Tiny bubbles provide tremendous propulsion in new microparticles research-Ben-Gurion U. June 21st, 2017
Enhanced photocatalytic activity by Cu2O nanoparticles integrated H2Ti3O7 nanotubes June 21st, 2017
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results April 27th, 2017
Nanometrics to Announce First Quarter Financial Results on May 2, 2017 April 11th, 2017
Arrowhead Pharmaceuticals to Webcast Fiscal 2017 First Quarter Results January 31st, 2017
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
University Technology Transfer & Patents
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||